Fine chemicals are low-volume, high-value products, predominantly including active pharmaceutical ingredients (APIs), agrochemicals, and flavors and fragrances. This report analyzes the global fine chemicals industry in terms of market size and profitability, key merger and acquisition activity, and current industry trends. The report provides detailed profiles of the leading 10 companies in the market and includes briefer overviews of other major players in the industry.
Table of Contents:
Executive summary 12
Industry overview 12
BASF 13
Lonza 13
DSM 14
Sumitomo Chemical 14
Merck KGaA 15
Lanxess (Saltigo) 16
Sigma-Aldrich 16
Jubilant Organosys 17
Johnson Matthey 17
Evonik Chemicals 18
Chapter 1 Introduction 20
What is this report about? 20
Methodology 20
Chapter 2 Industry overview 24
Summary 24
Fine chemicals – an overview 25
Different types of fine chemicals 26
Pharmaceutical intermediates 27
Agrochemical intermediates 28
Flavors and fragrances 28
Dyes and others 29
Market dynamics 29
Size and structure 29
Profitability 30
Competitive landscape 30
Manufacturing standards and their potential benefits 32
Potential benefits of the guideline 33
Key partnerships and M&A activity in the fine chemicals sector 34
Key trends 35
Advanced technologies 35
Increasing demand for HPAPIs 35
Relocation to emerging and fast growing markets 36
Increasing use of biotechnology and nanotechnology 36
Chapter 3 BASF 40
Summary 40
Company overview 41
Business segmentation 41
R&D focus 42
Financial performance 42
Growth strategies 44
Leading supplier of chemical intermediates 44
Verbund, an innovative approach 44
Diversified product portfolio 45
SWOT analysis 45
Chapter 4 Lonza 48
Summary 48
Company overview 49
Business segmentation 49
R&D focus 50
Financial performance 51
Growth strategies 52
Chemical manufacturing strengthens Lonza’s technology platform 52
Partnership with biopharmaceutical and chemical companies 52
SWOT analysis 54
Chapter 5 DSM 56
Summary 56
Company overview 57
Business segmentation 57
R&D focus 58
Financial performance 60
Growth strategies 61
Increasing R&D activity in emerging markets 61
Microreactors: a new technology for pharmaceutical production 61
SWOT analysis 62
Chapter 6 Sumitomo Chemical 64
Summary 64
Company overview 65
Business segmentation 65
R&D focus 66
Financial performance 67
Growth strategies 69
Strong progress in major R&D projects 69
Pursuing a new strategy of creative hybrid chemistry 69
Strong response to the EU’s REACH legislation for chemicals 69
Creation of next-generation chemical safety information management
database 70
SWOT analysis 71
Chapter 7 Merck KGaA Chemicals 74
Summary 74
Company overview 75
Business segmentation 75
R&D focus 76
Financial performance 76
Growth strategies 77
Merck KGaA and Millipore partnership for specialty products 77
New pharmaceutical production plant to increase Merck KGaA’s capacity in
Germany 78
Stronger presence in India through acquisition of Bangalore Genei 78
Merck Serono to build its R&D operations in China 78
SWOT analysis 79
Chapter 8 Lanxess (Saltigo) 82
Summary 82
Company overview 83
Business segmentation 83
R&D focus 84
Financial performance 84
Growth strategies 85
Expansion in BRIC countries 85
Advanced Intermediates segment 86
Custom manufacturing 86
SWOT analysis 87
Chapter 9 Sigma-Aldrich 90
Summary 90
Company overview 91
Business segmentation 91
R&D focus 92
Financial performance 92
Growth strategies 93
Strong focus on emerging markets 93
Partnerships and alliances 94
Targeting the high-growth biology segment 94
SWOT analysis 95
Chapter 10 Jubilant Organosys 98
Summary 98
Company overview 99
Business segmentation 100
R&D focus 101
Financial performance 101
Growth strategies 104
Integrated business model 104
Strong R&D and manufacturing services for intermediates and APIs 104
Positioning as an outsourcing partner of choice 105
SWOT analysis 106
Chapter 11 Johnson Matthey 108
Summary 108
Company overview 109
Business segmentation 109
R&D focus 110
Financial performance 111
Growth strategies 112
Johnson Matthey’s Sustainability 2017 initiative 112
Strong market position in APIs and contract manufacturing services 112
SWOT analysis 113
Chapter 12 Evonik Chemicals 116
Summary 116
Company overview 117
Business segmentation 117
R&D focus 117
Financial performance 118
Growth strategies 119
Specialty chemicals remain a key focus area for Evonik 119
Strong commitment to custom manufacturing business 120
SWOT analysis 121
Chapter 13 Other major players 124
Boehringer Ingelheim 124
Company overview 124
Recent financial performance 124
Divis Laboratories 125
Company overview 125
Recent financial performance 126
Pfizer CentreSource 127
Company overview 127
Recent financial performance 127
Cambrex 128
Company overview 128
Recent financial performance 128
Fabbrica Italiana Sintetici 129
Company overview 129
Recent financial performance 130
For more information visit
http://www.bharatbook.com/detail.asp?id=144567&rt=The-Top-10-Global-Fine-Chemicals-Companies-Industry-overview-key-trends-growth-strategies-financial-performance-and-SWOT-analysis.html
OR Contact us at
207, Hermes Atrium, Sector 11, CBD Belapur, Navi Mumbai – 400 614, India.
Phone : +91 22 2757 8668 / 2757 9438
Fax : +91 22 2757 9131
E-mail : info@bharatbook.com
Website : www.bharatbook.com
Follow us on twitter: http://twitter.com/3bbharatbook
Please visit our blog at http://bharatbookseo.blogsome.com
No comments:
Post a Comment